| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $12.9M | +27.8% |
| R&D Expense | $7.5M | -29.6% |
| SG&A Expense | $33.0M | +40.4% |
| Operating Income | -$52.2M | +24.8% |
| Pre-tax Income | -$113.4M | -118.4% |
| Income Tax | $2.9M | -68.5% |
| Net Income | -$116.3M | -90.6% |
| EPS (Basic) | -$1.28 | -88.2% |
| EPS (Diluted) | -$1.28 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $22.5M | -4.2% |
| Accounts Receivable | $1.5M | +62.5% |
| Current Assets | $27.9M | +4.9% |
| Total Assets | $61.7M | -19.2% |
| Current Liabilities | $34.6M | +61.8% |
| Total Liabilities | $114.7M | +364.3% |
| Stockholders' Equity | -$53.0M | -202.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$35.9M | +27.6% |
| Capital Expenditures | $5.0M | -66.2% |
| Investing Cash Flow | -$5.0M | +65.1% |
| Financing Cash Flow | $37.5M | — |
| Free Cash Flow | -$40.9M | +36.5% |
| -88.2% |